Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis

Article in Antioxidants (August 2024)

Pharmacological impacts of tanshinone on osteogenesis and osteoclastogenesis: a review

Article in Naunyn-Schmiedeberg's Archives of Pharmacology (August 2024)

Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight

Article in Metabolites (June 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.